How do exogenous steroids affect 24‑hour urine free cortisol and midnight salivary cortisol levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Effect of Exogenous Steroids on 24-Hour Urine Free Cortisol and Midnight Salivary Cortisol

Exogenous steroids will suppress both 24-hour urine free cortisol (UFC) and midnight salivary cortisol levels by suppressing the hypothalamic-pituitary-adrenal (HPA) axis, resulting in decreased endogenous cortisol production.

Mechanism and Expected Changes

When you administer exogenous glucocorticoids, they suppress ACTH secretion from the anterior pituitary through negative feedback 1. This leads to:

  • Markedly decreased endogenous cortisol production and its metabolites in urine 2
  • Suppressed midnight salivary cortisol reflecting the loss of normal circadian rhythm
  • The degree of suppression depends on the dose, duration, and potency of the exogenous steroid

Key Clinical Implications

For 24-Hour Urine Free Cortisol:

UFC will be significantly suppressed below normal reference ranges when patients are on exogenous glucocorticoids 2. The terminal cortisol metabolites show even more dramatic suppression than free cortisol itself. This occurs because:

  • Exogenous glucocorticoids (like prednisone, prednisolone, dexamethasone) suppress ACTH
  • Reduced ACTH leads to decreased adrenal cortisol synthesis
  • The measured UFC reflects only endogenous cortisol production, not the exogenous steroid (unless specifically measured) 3

For Midnight Salivary Cortisol:

Midnight salivary cortisol will be suppressed, losing the normal circadian variation. However, the specific effect depends on:

  • Timing of exogenous steroid administration relative to sample collection
  • Type of glucocorticoid used (some cross-react with cortisol assays, others don't)
  • Degree of HPA axis suppression

Critical Pitfalls to Avoid

Assay Cross-Reactivity Issues:

Most cortisol assays do NOT detect synthetic glucocorticoids like prednisone, prednisolone, or dexamethasone 3. This means:

  • You're measuring suppressed endogenous cortisol, not the therapeutic steroid
  • Results will appear falsely low, mimicking adrenal insufficiency
  • This is actually the expected finding, not a laboratory error

Timing Considerations:

According to 1, when assessing HPA axis recovery:

  • Morning serum cortisol should be measured at least 24 hours after the last glucocorticoid dose
  • This allows clearance of the exogenous steroid to assess endogenous production
  • The same principle applies to UFC and salivary cortisol measurements

Duration of Suppression:

HPA axis suppression can persist for months to years after stopping exogenous glucocorticoids 1:

  • Suppression may last 2-4 years after cessation
  • Recovery beyond 4 years is unlikely if suppression persists
  • Even intra-articular injections can suppress the axis for 4+ weeks 1

Diagnostic Context

If you're trying to diagnose Cushing's syndrome in someone on exogenous steroids:

  1. You cannot reliably use UFC or midnight salivary cortisol while they're taking glucocorticoids
  2. Stop the exogenous steroid first (if medically safe) and wait for clearance
  3. Look for iatrogenic Cushing's syndrome clinically (cushingoid features indicate fully suppressed HPA axis) 1
  4. Consider that patients with exogenous Cushing's features should be assumed to have complete HPA suppression 1

Recovery Assessment

When tapering exogenous steroids and wanting to assess HPA recovery 1:

  • Morning serum cortisol >300 nmol/L (10 μg/dL) suggests HPA recovery
  • 150-300 nmol/L (5-10 μg/dL) requires continued physiologic replacement and retesting
  • <150 nmol/L (5 μg/dL) indicates persistent suppression requiring continued replacement

The same suppressive principles apply to UFC and midnight salivary cortisol during this recovery period.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.